Using immunotherapy can reduce risk of returning skin cancer - Study

File image.

A new study shows using an immunotherapy can significantly reduce the risk of a patient's skin cancer returning.

Nearly two thirds of of patients treated with nivolumab at an earlier stage alongside surgery, experienced recurrence-free survival.

Anne Gribben from Dublin was diagnosed with stage three malignant melanoma in 2006 and is still cancer-free as a result of the treatment.

She was given one of two drug treatment options and says her health has been great since.

She said: "The results have been good because everything has been clear since and I started that in 2015."

- Digital Desk

More in this Section

Youghal pays tribute to golden racing duo

Michael D Higgins tells dissidents to reflect on their ‘appalling’ actions

Donegal bus driver had 49 faults with his vehicle

Corca Dhuibhne is on the map after local election fear


Lifestyle

Review: Theatre, Ulster American

Review: Beyoncé, Homecoming

Wish List: Mellow yellow in the bedroom and beyond

10 ways to help protect your child’s online reputation

More From The Irish Examiner